peptide elongation factor 2 has been researched along with Thrombocytopenia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Fan, X; Geng, Y; Hou, Y; Jiang, H; Li, L; Liu, J; Shen, Y; Wang, L; Wang, Y; Xin, M; Xu, Y; Zhang, L | 1 |
1 other study(ies) available for peptide elongation factor 2 and Thrombocytopenia
| Article | Year |
|---|---|
Inhibition of LDHA to induce eEF2 release enhances thrombocytopoiesis.
Topics: Animals; Blood Platelets; Elongation Factor 2 Kinase; Enzyme Inhibitors; L-Lactate Dehydrogenase; Megakaryocytes; Mice; Mice, Knockout; NAD; Peptide Elongation Factor 2; Thrombocytopenia; Thrombopoiesis | 2022 |